{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T21:02:06Z","timestamp":1785531726087,"version":"3.56.0"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T00:00:00Z","timestamp":1747958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T00:00:00Z","timestamp":1747958400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hypertens Res"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1038\/s41440-025-02239-3","type":"journal-article","created":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T03:04:50Z","timestamp":1747969490000},"page":"2152-2162","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Blood pressure-lowering treatment for pregnant women with non-severe hypertension: a systematic review and meta-analysis"],"prefix":"10.1038","volume":"48","author":[{"given":"Makiko","family":"Abe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukiko","family":"Shinohara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoko","family":"Arata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirohito","family":"Metoki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ako","family":"Fukami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisatomi","family":"Arima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asako","family":"Mito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,23]]},"reference":[{"key":"2239_CR1","doi-asserted-by":"publisher","first-page":"e306","DOI":"10.1016\/S2214-109X(23)00468-0","volume":"12","author":"JP Souza","year":"2024","unstructured":"Souza JP, Day LT, Rezende-Gomes AC, Zhang J, Mori R, Baguiya A, et al. A global analysis of the determinants of maternal health and transitions in maternal mortality. Lancet Glob Health. 2024;12:e306\u2013e316.","journal-title":"Lancet Glob Health"},{"key":"2239_CR2","doi-asserted-by":"publisher","DOI":"10.1186\/s12884-021-03809-2","volume":"21","author":"W Wang","year":"2021","unstructured":"Wang W, Xie X, Yuan T, Wang Y, Zhao F, Zhou Z, et al. Epidemiological trends of maternal hypertensive disorders of pregnancy at the global, regional, and national levels: a population-based study. BMC Pregnancy Childbirth. 2021;21:364.","journal-title":"BMC Pregnancy Childbirth"},{"key":"2239_CR3","volume":"3","author":"AA Radparvar","year":"2024","unstructured":"Radparvar AA, Vani K, Fiori K, Gupta S, Chavez P, Fisher M, et al. Hypertensive disorders of pregnancy. Innov Manag Strateg JACC Adv. 2024;3:100864.","journal-title":"Innov Manag Strateg JACC Adv"},{"key":"2239_CR4","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1016\/j.jacc.2022.03.335","volume":"79","author":"JJ Stuart","year":"2022","unstructured":"Stuart JJ, Tanz LJ, Rimm EB, Spiegelman D, Missmer SA, Mukamal KJ, et al. Cardiovascular risk factors mediate the long-term maternal risk associated with hypertensive disorders of pregnancy. J Am Coll Cardiol. 2022;79:1901\u201313.","journal-title":"J Am Coll Cardiol"},{"key":"2239_CR5","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1056\/NEJMoa1404595","volume":"372","author":"LA Magee","year":"2015","unstructured":"Magee LA, von Dadelszen P, Rey E, Ross S, Asztalos E, Murphy KE, et al. Less-tight versus tight control of hypertension in pregnancy. N. Engl J Med. 2015;372:407\u201317.","journal-title":"N. Engl J Med"},{"key":"2239_CR6","first-page":"Cd002252","volume":"10","author":"E Abalos","year":"2018","unstructured":"Abalos E, Duley L, Steyn DW, Gialdini C. Antihypertensive drug therapy for mild to moderate hypertension during pregnancy. Cochrane Database Syst Rev. 2018;10:Cd002252.","journal-title":"Cochrane Database Syst Rev"},{"key":"2239_CR7","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.preghy.2021.09.008","volume":"27","author":"LA Magee","year":"2022","unstructured":"Magee LA, Brown MA, Hall DR, Gupte S, Hennessy A, Karumanchi SA, et al. The 2021 International Society for the Study of Hypertension in Pregnancy classification, diagnosis & management recommendations for international practice. Pregnancy Hypertens. 2022;27:148\u201369.","journal-title":"Pregnancy Hypertens"},{"key":"2239_CR8","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/ijgo.13763","volume":"154","author":"LC Poon","year":"2021","unstructured":"Poon LC, Magee LA, Verlohren S, Shennan A, von Dadelszen P, Sheiner E, et al. A literature review and best practice advice for second and third trimester risk stratification, monitoring, and management of pre-eclampsia: Compiled by the Pregnancy and Non-Communicable Diseases Committee of FIGO (the International Federation of Gynecology and Obstetrics). Int J Gynaecol Obstet. 2021;154:3\u201331.","journal-title":"Int J Gynaecol Obstet"},{"key":"2239_CR9","doi-asserted-by":"publisher","first-page":"582","DOI":"10.5694\/mja2.52312","volume":"220","author":"R Shanmugalingam","year":"2024","unstructured":"Shanmugalingam R, Barrett HL, Beech A, Bowyer L, Crozier T, Davidson A, et al. A summary of the 2023 Society of Obstetric Medicine of Australia and New Zealand (SOMANZ) hypertension in pregnancy guideline. Med J Aust. 2024;220:582\u201391.","journal-title":"Med J Aust"},{"key":"2239_CR10","unstructured":"The National Institute for Health and Care Excellence (NICE) guideline. Hypertension in pregnancy: diagnosis and management. (https:\/\/www.nice.org.uk\/guidance\/ng133) Accessed on Dec 10th, 2024."},{"key":"2239_CR11","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1056\/NEJMoa2201295","volume":"386","author":"AT Tita","year":"2022","unstructured":"Tita AT, Szychowski JM, Boggess K, Dugoff L, Sibai B, Lawrence K, et al. Treatment for mild chronic hypertension during pregnancy. N Engl J Med. 2022;386:1781\u201392.","journal-title":"N Engl J Med"},{"key":"2239_CR12","unstructured":"Clinical Guidance for the Integration of the Findings of the Chronic Hypertension and Pregnancy (CHAP) Study (https:\/\/www.acog.org\/clinical\/clinical-guidance\/practice-advisory\/articles\/2022\/04\/clinical-guidance-for-the-integration-of-the-findings-of-the-chronic-hypertension-and-pregnancy-chap-study) Accessed on Dec 10th, 2024."},{"key":"2239_CR13","first-page":"3912","volume":"45","author":"JW McEvoy","year":"2024","unstructured":"McEvoy JW, McCarthy CP, Bruno RM, Brouwers S, Canavan MD, Ceconi C, et al. ESC Guidelines for the management of elevated blood pressure and hypertension. Eur Heart J 2024. 2024;45:3912\u20134018.","journal-title":"Eur Heart J 2024"},{"key":"2239_CR14","doi-asserted-by":"publisher","first-page":"1874","DOI":"10.1097\/HJH.0000000000003480","volume":"41","author":"G Mancia","year":"2023","unstructured":"Mancia G, Kreutz R, Brunstr\u00f6m M, Burnier M, Grassi G, Januszewicz A, et al. 2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension: Endorsed by the International Society of Hypertension (ISH) and the European Renal Association (ERA). J Hypertens. 2023;41:1874\u20132071.","journal-title":"J Hypertens"},{"key":"2239_CR15","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Bmj. 2021;372:n71.","journal-title":"Bmj"},{"key":"2239_CR16","doi-asserted-by":"publisher","first-page":"l4898","DOI":"10.1136\/bmj.l4898","volume":"366","author":"JAC Sterne","year":"2019","unstructured":"Sterne JAC, Savovi\u0107 J, Page MJ, Elbers RG, Blencowe NS, Boutron I, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. Bmj. 2019;366:l4898.","journal-title":"Bmj"},{"key":"2239_CR17","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1002\/sim.1186","volume":"21","author":"JP Higgins","year":"2002","unstructured":"Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21:1539\u201358.","journal-title":"Stat Med"},{"key":"2239_CR18","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1177\/1536867X0800800403","volume":"8","author":"RogerM Harbord","year":"2008","unstructured":"Harbord RogerM, Higgins JulianPT. Meta-regression in stata. Stata J. 2008;8:493\u2013519.","journal-title":"Stata J"},{"key":"2239_CR19","doi-asserted-by":"publisher","first-page":"9","DOI":"10.14715\/cmb\/2017.63.11.16","volume":"66","author":"X Xiang","year":"2020","unstructured":"Xiang X, Wang F, Zhao N, Zhou Z. Treatment of pregnancy-induced hypertension compared with labetalol, low dose aspirin and placebo. Cell Mol Biol (Noisy-le-Gd). 2020;66:9\u201313.","journal-title":"Cell Mol Biol (Noisy-le-Gd)"},{"key":"2239_CR20","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.preghy.2019.05.009","volume":"17","author":"M Salama","year":"2019","unstructured":"Salama M, Rezk M, Gaber W, Hamza H, Marawan H, Gamal A, et al. Methyldopa versus nifedipine or no medication for treatment of chronic hypertension during pregnancy: A multicenter randomized clinical trial. Pregnancy Hypertens. 2019;17:54\u201358.","journal-title":"Pregnancy Hypertens"},{"key":"2239_CR21","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1007\/s00404-011-2205-2","volume":"285","author":"SN Molvi","year":"2012","unstructured":"Molvi SN, Mir S, Rana VS, Jabeen F, Malik AR. Role of antihypertensive therapy in mild to moderate pregnancy-induced hypertension: a prospective randomized study comparing labetalol with alpha methyldopa. Arch Gynecol Obstet. 2012;285:1553\u201362.","journal-title":"Arch Gynecol Obstet"},{"key":"2239_CR22","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1515\/JPM.2008.060","volume":"36","author":"AA El Guindy","year":"2008","unstructured":"El Guindy AA, Nabhan AF. A randomized trial of tight vs. less tight control of mild essential and gestational hypertension in pregnancy. J Perinat Med. 2008;36:413\u20138.","journal-title":"J Perinat Med"},{"key":"2239_CR23","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1111\/j.1471-0528.2007.01315.x","volume":"114","author":"LA Magee","year":"2007","unstructured":"Magee LA, von Dadelszen P, Chan S, Gafni A, Gruslin A, Helewa M, et al. The control of hypertension in pregnancy study pilot trial. Bjog. 2007;114:770.e713-720","journal-title":"Bjog"},{"key":"2239_CR24","doi-asserted-by":"publisher","first-page":"172-5","DOI":"10.4314\/eamj.v79i4.8872","volume":"79","author":"EM Elhassan","year":"2002","unstructured":"Elhassan EM, Mirghani OA, Habour AB, Adam I. Methyldopa versus no drug treatment in the management of mild pre-eclampsia. East Afr Med J. 2002;79:172-5.","journal-title":"East Afr Med J"},{"key":"2239_CR25","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1111\/j.1471-0528.1998.tb10201.x","volume":"105","author":"F Parazzini","year":"1998","unstructured":"Parazzini F, Benedetto C, Bortolus R, Ricci E, Marozio L, Donvito V, et al. Nifedipine versus expectant management in mild to moderate hypertension in pregnancy. Br J Obstet Gynaecol. 1998;105:718\u201322.","journal-title":"Br J Obstet Gynaecol"},{"key":"2239_CR26","first-page":"373","volume":"6","author":"D Catalano","year":"1997","unstructured":"Catalano D, Ercolano S, Pollio F, Ascione L, Russo C, De Santi B, et al. Evaluation of nifedipine monotherapy in the management of pregnancy hypertension. G Ital Di Ostet e Ginecol. 1997;6:373\u20135.","journal-title":"G Ital Di Ostet e Ginecol"},{"key":"2239_CR27","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1016\/0002-9378(95)90357-7","volume":"173","author":"DH Wide-Swensson","year":"1995","unstructured":"Wide-Swensson DH, Ingemarsson I, Lunell NO, Forman A, Skajaa K, Lindberg B, et al. Calcium channel blockade (isradipine) in treatment of hypertension in pregnancy: a randomized placebo-controlled study. Am J Obstet Gynecol. 1995;173:872\u20138.","journal-title":"Am J Obstet Gynecol"},{"key":"2239_CR28","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1111\/j.1471-0528.1992.tb13698.x","volume":"99","author":"CJ Pickles","year":"1992","unstructured":"Pickles CJ, Broughton Pipkin F, Symonds EM. A randomised placebo controlled trial of labetalol in the treatment of mild to moderate pregnancy induced hypertension. Br J Obstet Gynaecol. 1992;99:964\u20138.","journal-title":"Br J Obstet Gynaecol"},{"key":"2239_CR29","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1016\/S0002-9378(12)80005-6","volume":"167","author":"BM Sibai","year":"1992","unstructured":"Sibai BM, Barton JR, Sarinoglu AklS, Mercer C. BM. A randomized prospective comparison of nifedipine and bed rest versus bed rest alone in the management of preeclampsia remote from term. Am J Obstet Gynecol. 1992;167:879\u201384.","journal-title":"Am J Obstet Gynecol"},{"key":"2239_CR30","doi-asserted-by":"publisher","first-page":"207","DOI":"10.3109\/10641959209031044","volume":"11","author":"G Bott-Kanner","year":"1992","unstructured":"Bott-Kanner G, Hirsch M, Friedman S, Boner G, Ovadia J, Merlob P, et al. Antihypertensive therapy in the management of hypertension in pregnancy - A clinical double-blind study of pindolol. Clin Exp Hypertens Part B: Hypertens Pregnancy. 1992;11:207\u201320.","journal-title":"Clin Exp Hypertens Part B: Hypertens Pregnancy"},{"key":"2239_CR31","doi-asserted-by":"publisher","first-page":"223","DOI":"10.3109\/01443619209004032","volume":"12","author":"DJ Cruickshank","year":"1992","unstructured":"Cruickshank DJ, Campbell D, Robertson AA, Macgillivray I. Intra-uterine growth retardation and maternal labetatol treatment in a random allocation controlled study. J Obstet Gynaecol. 1992;12:223\u20137.","journal-title":"J Obstet Gynaecol"},{"key":"2239_CR32","doi-asserted-by":"publisher","first-page":"378","DOI":"10.5694\/j.1326-5377.1991.tb121126.x","volume":"154","author":"AF Phippard","year":"1991","unstructured":"Phippard AF, Fischer WE, Horvath JS, Child AG, Korda AR, Henderson-Smart D, et al. Early blood pressure control improves pregnancy outcome in primigravid women with mild hypertension. Med J Aust. 1991;154:378\u201382.","journal-title":"Med J Aust"},{"key":"2239_CR33","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1111\/j.1471-0528.1991.tb13387.x","volume":"98","author":"S Blake","year":"1991","unstructured":"Blake S. MacDonald D. The prevention of the maternal manifestations of pre-eclampsia by intensive antihypertensive treatment. Br J Obstet Gynaecol. 1991;98:244\u20138.","journal-title":"Br J Obstet Gynaecol"},{"key":"2239_CR34","doi-asserted-by":"publisher","first-page":"333","DOI":"10.3109\/10641959109012919","volume":"10","author":"DJ Cruickshank","year":"1991","unstructured":"Cruickshank DJ, Robertson AA, Campbell DM, MacGillivray I. Maternal obstetric outcome measures in a randomised controlled study of labetalol in the treatment of hypertension in pregnancy. Clin Exp Hypertens Part B: Hypertens Pregnancy. 1991;10:333\u201344.","journal-title":"Clin Exp Hypertens Part B: Hypertens Pregnancy"},{"key":"2239_CR35","unstructured":"Odendaal H, Schabort I, Pattinson R. Prazosin for the treatment of hypertension in pregnancy: a randomized control trial. Oxford Database of Perinatal Trials, Version 12, Disk Issue 6, Autumn Chalmers l (ed) Oxford: Oxford University Press 1991."},{"key":"2239_CR36","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1136\/bmj.301.6752.587","volume":"301","author":"L Butters","year":"1990","unstructured":"Butters L, Kennedy S, Rubin PC. Atenolol in essential hypertension during pregnancy. Bmj. 1990;301:587\u20139.","journal-title":"Bmj"},{"key":"2239_CR37","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1016\/0002-9378(90)91297-P","volume":"162","author":"BM Sibai","year":"1990","unstructured":"Sibai BM, Mabie WC, Shamsa F, Villar MA, Anderson GD. A comparison of no medication versus methyldopa or labetalol in chronic hypertension during pregnancy. Am J Obstet Gynecol. 1990;162:960\u20136. discussion 966-967","journal-title":"Am J Obstet Gynecol"},{"key":"2239_CR38","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1111\/j.1471-0528.1990.tb01738.x","volume":"97","author":"PF Plouin","year":"1990","unstructured":"Plouin PF, Breart G, Llado J, Dalle M, Keller ME, Goujon H, et al. A randomized comparison of early with conservative use of antihypertensive drugs in the management of pregnancy-induced hypertension. Br J Obstet Gynaecol. 1990;97:134\u201341.","journal-title":"Br J Obstet Gynaecol"},{"key":"2239_CR39","unstructured":"Li CY, Lao TT, Yu KM, Wong SP, Leung CF. The effect of labetalol on mild pre-eclampsia. Proceedings of the 7th World Congress of Hypertension in Pregnancy; Perugia, Italy 1990:191."},{"key":"2239_CR40","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1111\/j.1471-0528.1989.tb01574.x","volume":"96","author":"CJ Pickles","year":"1989","unstructured":"Pickles CJ, Symonds EM, Pipkin Broughton. F. The fetal outcome in a randomized double-blind controlled trial of labetalol versus placebo in pregnancy-induced hypertension. Br J Obstet Gynaecol. 1989;96:38\u201343.","journal-title":"Br J Obstet Gynaecol"},{"key":"2239_CR41","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1111\/j.1471-0528.1988.tb06818.x","volume":"95","author":"SW Lindow","year":"1988","unstructured":"Lindow SW, Davies N, Davey DA, Smith JA. The effect of sublingual nifedipine on uteroplacental blood flow in hypertensive pregnancy. Br J Obstet Gynaecol. 1988;95:1276\u201381.","journal-title":"Br J Obstet Gynaecol"},{"key":"2239_CR42","first-page":"323","volume":"70","author":"BM Sibai","year":"1987","unstructured":"Sibai BM, Gonzalez AR, Mabie WC, Moretti M. A comparison of labetalol plus hospitalization versus hospitalization alone in the management of preeclampsia remote from term. Obstet Gynecol. 1987;70:323\u20137.","journal-title":"Obstet Gynecol"},{"key":"2239_CR43","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/0020-7292(87)90181-0","volume":"25","author":"C Weitz","year":"1987","unstructured":"Weitz C, Khouzami V, Maxwell K, Johnson JW. Treatment of hypertension in pregnancy with methyldopa: a randomized double blind study. Int J Gynaecol Obstet. 1987;25:35\u201340.","journal-title":"Int J Gynaecol Obstet"},{"key":"2239_CR44","doi-asserted-by":"publisher","first-page":"505","DOI":"10.3109\/00016348509156729","volume":"64","author":"S H\u00f6gstedt","year":"1985","unstructured":"H\u00f6gstedt S, Lindeberg S, Axelsson O, Lindmark G, Rane A, Sandstr\u00f6m B, et al. A prospective controlled trial of metoprolol-hydralazine treatment in hypertension during pregnancy. Acta Obstet Gynecol Scand. 1985;64:505\u201310.","journal-title":"Acta Obstet Gynecol Scand"},{"key":"2239_CR45","first-page":"85","volume":"8","author":"S Kahhale","year":"1985","unstructured":"Kahhale S, Zugaib M, Carrara W, Paula F, Sabbaga E, Neme B. Comparative study of chronic hypertensive pregnant women treated and non-treated with pindolol. Ginecologia e Obstetr\u00edcia Brasileiras. 1985;8:85\u201389.","journal-title":"Ginecologia e Obstetr\u00edcia Brasileiras"},{"key":"2239_CR46","doi-asserted-by":"publisher","first-page":"90","DOI":"10.3109\/00365518409085385","volume":"169","author":"K Wichman","year":"1984","unstructured":"Wichman K, Ryd\u00e9n G, Karlberg BE. A placebo controlled trial of metoprolol in the treatment of hypertension in pregnancy. Scand J Clin Lab Invest Suppl. 1984;169:90\u201395.","journal-title":"Scand J Clin Lab Invest Suppl"},{"key":"2239_CR47","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/S0002-9378(84)80145-3","volume":"150","author":"PC Rubin","year":"1984","unstructured":"Rubin PC, Butters L, Clark D, Sumner D, Belfield A, Pledger D, et al. Obstetric aspects of the use in pregnancy-associated hypertension of the beta-adrenoceptor antagonist atenolol. Am J Obstet Gynecol. 1984;150:389\u201392.","journal-title":"Am J Obstet Gynecol"},{"key":"2239_CR48","first-page":"431","volume":"1","author":"PC Rubin","year":"1983","unstructured":"Rubin PC, Butters L, Clark DM, Reynolds B, Sumner DJ, Steedman D, et al. Placebo-controlled trial of atenolol in treatment of pregnancy-associated hypertension. Lancet. 1983;1:431\u20134.","journal-title":"Lancet"},{"key":"2239_CR49","first-page":"148","volume":"591","author":"J Walker","year":"1982","unstructured":"Walker J, Crooks A, Erwin L, Calder AA. EM. Labetalol in pregnancy-induced hypertension: fetal and maternal effects. Int Congr Ser. 1982;591:148\u201360.","journal-title":"Int Congr Ser"},{"key":"2239_CR50","first-page":"557","volume":"57","author":"SI Welt","year":"1981","unstructured":"Welt SI, Dorminy JH 3rd, Jelovsek FR, Crenshaw MC, Gall SA. The effects of prophylactic management and therapeutics on hypertensive disease in pregnancy: preliminary studies. Obstet Gynecol. 1981;57:557\u201365.","journal-title":"Obstet Gynecol"},{"key":"2239_CR51","first-page":"489","volume":"53","author":"F Arias","year":"1979","unstructured":"Arias F, Zamora J. Antihypertensive treatment and pregnancy outcome in patients with mild chronic hypertension. Obstet Gynecol. 1979;53:489\u201394.","journal-title":"Obstet Gynecol"},{"key":"2239_CR52","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/0378-3782(77)90029-9","volume":"1","author":"LM Mutch","year":"1977","unstructured":"Mutch LM, Moar VA, Ounsted MK, Redman CW. Hypertension during pregnancy, with and without specific hypotensive treatment. I. Perinatal factors and neonatal morbidity. Early Hum Dev. 1977;1:47\u201357.","journal-title":"Early Hum Dev"},{"key":"2239_CR53","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1111\/j.1471-0528.1977.tb12616.x","volume":"84","author":"CW Redman","year":"1977","unstructured":"Redman CW, Beilin LJ, Bonnar J. Treatment of hypertension in pregnancy with methyldopa: blood pressure control and side effects. Br J Obstet Gynaecol. 1977;84:419\u201326.","journal-title":"Br J Obstet Gynaecol"},{"key":"2239_CR54","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/S0140-6736(76)90597-3","volume":"2","author":"CW Redman","year":"1976","unstructured":"Redman CW, Beilin LJ, Bonnar J, Ounsted MK. Fetal outcome in trial of antihypertensive treatment in pregnancy. Lancet. 1976;2:753\u20136.","journal-title":"Lancet"},{"key":"2239_CR55","first-page":"871","volume":"30","author":"PA Baker","year":"1968","unstructured":"Baker PA, Chadd MA, Humphreys DM, Leather HM. Controlled trial of hypotensive agents in hypertension in pregnancy. Proc Br Card Soc Br Heart J. 1968;30:871.","journal-title":"Proc Br Card Soc Br Heart J"},{"key":"2239_CR56","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1016\/S0140-6736(68)90650-8","volume":"2","author":"HM Leather","year":"1968","unstructured":"Leather HM, Humphreys DM, Baker P, Chadd MA. A controlled trial of hypotensive agents in hypertension in pregnancy. Lancet. 1968;2:488\u201390.","journal-title":"Lancet"},{"key":"2239_CR57","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1161\/HYPERTENSIONAHA.121.18415","volume":"79","author":"JN Bone","year":"2022","unstructured":"Bone JN, Sandhu A, Abalos ED, Khalil A, Singer J, Prasad S, et al. Oral Antihypertensives for Nonsevere Pregnancy Hypertension: Systematic Review, Network Meta- and Trial Sequential Analyses. Hypertension. 2022;79:614\u201328.","journal-title":"Hypertension"},{"key":"2239_CR58","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1002\/ijgo.14634","volume":"162","author":"Z Chen","year":"2023","unstructured":"Chen Z, Wang J, Carru C, Chen Y, Li Z. Treatment for mild hypertension in pregnancy with different strategies: A systematic review and meta-analysis. Int J Gynaecol Obstet. 2023;162:202\u201310.","journal-title":"Int J Gynaecol Obstet"},{"key":"2239_CR59","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1002\/clc.24013","volume":"46","author":"A Attar","year":"2023","unstructured":"Attar A, Hosseinpour A, Moghadami M. The impact of antihypertensive treatment of mild to moderate hypertension during pregnancy on maternal and neonatal outcomes: An updated meta-analysis of randomized controlled trials. Clin Cardiol. 2023;46:467\u201376.","journal-title":"Clin Cardiol"},{"key":"2239_CR60","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/s41440-021-00763-6","volume":"45","author":"A Ueda","year":"2022","unstructured":"Ueda A, Hasegawa M, Matsumura N, Sato H, Kosaka K, Abiko K, et al. Lower systolic blood pressure levels in early pregnancy are associated with a decreased risk of early-onset superimposed preeclampsia in women with chronic hypertension: a multicenter retrospective study. Hypertens Res. 2022;45:135\u201345.","journal-title":"Hypertens Res"},{"key":"2239_CR61","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1161\/HYPERTENSIONAHA.118.11196","volume":"72","author":"A Hauspurg","year":"2018","unstructured":"Hauspurg A, Sutton EF, Catov JM, Caritis SN. Aspirin effect on adverse pregnancy outcomes associated with stage 1 hypertension in a high-risk cohort. Hypertension. 2018;72:202\u20137.","journal-title":"Hypertension"},{"key":"2239_CR62","doi-asserted-by":"crossref","unstructured":"Harper LM, Kuo HC, Boggess K, Dugoff L, Sibai B, Lawrence K, et al. Blood pressure control in pregnant patients with chronic hypertension and diabetes: should <130\/80 be the target? Am J Obstet Gynecol. 2024.","DOI":"10.1016\/j.ajog.2022.11.023"},{"key":"2239_CR63","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1097\/AOG.0000000000005410","volume":"142","author":"EJ Bailey","year":"2023","unstructured":"Bailey EJ, Tita ATN, Leach J, Boggess K, Dugoff L, Sibai B, et al. Perinatal outcomes associated with management of stage 1 hypertension. Obstet Gynecol. 2023;142:1395\u2013404.","journal-title":"Obstet Gynecol"},{"key":"2239_CR64","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/j.ajog.2022.10.004","volume":"228","author":"LJ Slade","year":"2023","unstructured":"Slade LJ, Mistry HD, Bone JN, Wilson M, Blackman M, Syeda N, et al. American College of Cardiology and American Heart Association blood pressure categories-a systematic review of the relationship with adverse pregnancy outcomes in the first half of pregnancy. Am J Obstet Gynecol. 2023;228:418\u2013429.e434.","journal-title":"Am J Obstet Gynecol"},{"key":"2239_CR65","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.ajog.2023.01.013","volume":"229","author":"LJ Slade","year":"2023","unstructured":"Slade LJ, Wilson M, Mistry HD, Bone JN, Bello NA, Blackman M, et al. The 2017 American College of Cardiology and American Heart Association blood pressure categories in the second half of pregnancy-a systematic review of their association with adverse pregnancy outcomes. Am J Obstet Gynecol. 2023;229:101\u201317.","journal-title":"Am J Obstet Gynecol"},{"key":"2239_CR66","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1111\/aogs.12877","volume":"95","author":"LA Magee","year":"2016","unstructured":"Magee LA, von Dadelszen P, Singer J, Lee T, Rey E, Ross S, et al. Can adverse maternal and perinatal outcomes be predicted when blood pressure becomes elevated? Secondary analyses from the CHIPS (Control of Hypertension In Pregnancy Study) randomized controlled trial. Acta Obstet Gynecol Scand. 2016;95:763\u201376.","journal-title":"Acta Obstet Gynecol Scand"},{"key":"2239_CR67","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1038\/s41371-024-00944-z","volume":"38","author":"Q Nie","year":"2024","unstructured":"Nie Q, Liang W, Xue Y, Pan L, Jiang M, He F. Chronic hypertension diagnosed before or during pregnancy and its effects on pregnancy outcomes. J Hum Hypertens. 2024;38:758\u201364.","journal-title":"J Hum Hypertens"},{"key":"2239_CR68","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1002\/uog.17493","volume":"50","author":"AM Panaitescu","year":"2017","unstructured":"Panaitescu AM, Syngelaki A, Prodan N, Akolekar R, Nicolaides KH. Chronic hypertension and adverse pregnancy outcome: a cohort study. Ultrasound Obstet Gynecol. 2017;50:228\u201335.","journal-title":"Ultrasound Obstet Gynecol"},{"key":"2239_CR69","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1038\/s41440-020-00537-6","volume":"44","author":"K Naruse","year":"2021","unstructured":"Naruse K, Shigemi D, Hashiguchi M, Imamura M, Yasunaga H, Arai T. Placental abruption in each hypertensive disorders of pregnancy phenotype: a retrospective cohort study using a national inpatient database in Japan. Hypertens Res. 2021;44:232\u20138.","journal-title":"Hypertens Res"},{"key":"2239_CR70","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/s40292-023-00582-5","volume":"30","author":"R C\u00edfkov\u00e1","year":"2023","unstructured":"C\u00edfkov\u00e1 R. Hypertension in pregnancy: a diagnostic and therapeutic overview. High Blood Press Cardiovasc Prev. 2023;30:289\u2013303.","journal-title":"High Blood Press Cardiovasc Prev"},{"key":"2239_CR71","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1001\/jama.2021.14781","volume":"326","author":"KW Davidson","year":"2021","unstructured":"Davidson KW, Barry MJ, Mangione CM, Cabana M, Caughey AB, Davis EM, et al. Aspirin use to prevent preeclampsia and related morbidity and mortality: US preventive services task force recommendation statement. JAMA. 2021;326:1186\u201391.","journal-title":"JAMA"}],"container-title":["Hypertension Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41440-025-02239-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41440-025-02239-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41440-025-02239-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T17:01:14Z","timestamp":1757178074000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41440-025-02239-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,23]]},"references-count":71,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["2239"],"URL":"https:\/\/doi.org\/10.1038\/s41440-025-02239-3","relation":{},"ISSN":["0916-9636","1348-4214"],"issn-type":[{"value":"0916-9636","type":"print"},{"value":"1348-4214","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,23]]},"assertion":[{"value":"5 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}